- MOQ2 Pack(s)
- Supply TypeManufacturer, Exporter, Supplier, Retailer
- Preferred Buyer Location All Countries Except India
Lenvima 24mg Lenvima (lenvatinib) is a receptor tyrosine kinase (RTK) inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). Lenvima is specifically indicated for use in combination with everolimus for the treatment of patients with advanced RCC following one prior anti-angiogenic therapy.